Dos Passos R, Santos C, Priviero F, Briones A, Tostes R, Webb R
Hypertension. 2024; 81(7):1411-1423.
PMID: 38686582
PMC: 11168883.
DOI: 10.1161/HYPERTENSIONAHA.124.21712.
Anyfanti P, Dara A, Angeloudi E, Bekiari E, Dimitroulas T, Kitas G
J Inflamm Res. 2021; 14:6893-6906.
PMID: 34934338
PMC: 8684400.
DOI: 10.2147/JIR.S276986.
Murray E, Nosalski R, MacRitchie N, Tomaszewski M, Maffia P, Harrison D
Cardiovasc Res. 2021; 117(13):2589-2609.
PMID: 34698811
PMC: 9825256.
DOI: 10.1093/cvr/cvab330.
Teklu M, Parel P, Mehta N
Psoriasis (Auckl). 2021; 11:99-108.
PMID: 34322373
PMC: 8312325.
DOI: 10.2147/PTT.S320016.
Kim S, Kwak S, Choe J
Medicine (Baltimore). 2020; 99(9):e19415.
PMID: 32118795
PMC: 7478791.
DOI: 10.1097/MD.0000000000019415.
Pro-inflammatory Cytokines and Resistant Hypertension: Potential for Novel Treatments?.
Pioli M, Faria A
Curr Hypertens Rep. 2019; 21(12):95.
PMID: 31773311
DOI: 10.1007/s11906-019-1003-2.
Impaired renal functions in Pakistani cohort of rheumatoid arthritis.
Wagan A, Nasir S, Rahim A, Khan D
Pak J Med Sci. 2019; 35(4):905-910.
PMID: 31372115
PMC: 6659054.
DOI: 10.12669/pjms.35.4.564.
Low serum IGF1 is associated with hypertension and predicts early cardiovascular events in women with rheumatoid arthritis.
Erlandsson M, Lyngfelt L, Aberg N, Wasen C, Espino R, Toyra Silfversward S
BMC Med. 2019; 17(1):141.
PMID: 31327319
PMC: 6643304.
DOI: 10.1186/s12916-019-1374-x.
Mechanisms of hypertension in autoimmune rheumatic diseases.
Taylor E, Wolf V, Dent E, Ryan M
Br J Pharmacol. 2019; 176(12):1897-1913.
PMID: 30714094
PMC: 6534791.
DOI: 10.1111/bph.14604.
Angiotensin receptor and tumor necrosis factor-α activation contributes to glucose intolerance independent of systolic blood pressure in obese rats.
Rodriguez R, Lee A, Mathis K, Broome H, Thorwald M, Martinez B
Am J Physiol Renal Physiol. 2018; 315(4):F1081-F1090.
PMID: 29993275
PMC: 6230730.
DOI: 10.1152/ajprenal.00156.2018.
Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases.
Bartoloni E, Alunno A, Gerli R
Nat Rev Cardiol. 2017; 15(1):33-44.
PMID: 28836617
DOI: 10.1038/nrcardio.2017.118.
Constitutive smooth muscle tumour necrosis factor regulates microvascular myogenic responsiveness and systemic blood pressure.
Kroetsch J, Levy A, Zhang H, Aschar-Sobbi R, Lidington D, Offermanns S
Nat Commun. 2017; 8:14805.
PMID: 28378814
PMC: 5382284.
DOI: 10.1038/ncomms14805.
Tumor Necrosis Factor-α Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis.
Desai R, Solomon D, Schneeweiss S, Danaei G, Liao K, Kim S
Epidemiology. 2016; 27(3):414-22.
PMID: 26808597
PMC: 5497216.
DOI: 10.1097/EDE.0000000000000446.
Cardiovascular comorbidity in rheumatic diseases.
Nurmohamed M, Heslinga M, Kitas G
Nat Rev Rheumatol. 2015; 11(12):693-704.
PMID: 26282082
DOI: 10.1038/nrrheum.2015.112.
A methodological approach to non-invasive assessments of vascular function and morphology.
Sandoo A, Kitas G
J Vis Exp. 2015; (96).
PMID: 25741637
PMC: 4354622.
DOI: 10.3791/52339.
Dual regulation of tumor necrosis factor-α on myosin light chain phosphorylation in vascular smooth muscle.
Chen M, Ma L, Hall J, Liu X, Ying Z
Am J Physiol Heart Circ Physiol. 2014; 308(5):H398-406.
PMID: 25502110
PMC: 4346769.
DOI: 10.1152/ajpheart.00691.2014.
Tumor necrosis factor-α inhibition attenuates middle cerebral artery remodeling but increases cerebral ischemic damage in hypertensive rats.
Pires P, Girgla S, Moreno G, McClain J, Dorrance A
Am J Physiol Heart Circ Physiol. 2014; 307(5):H658-69.
PMID: 25015967
PMC: 4280151.
DOI: 10.1152/ajpheart.00018.2014.
Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: a six-year prospective study.
Sandoo A, Chanchlani N, Hodson J, Smith J, Douglas K, Kitas G
Arthritis Res Ther. 2013; 15(6):R203.
PMID: 24289091
PMC: 3979105.
DOI: 10.1186/ar4396.
Arterial hypertension assessed "out-of-office" in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated "white....
Protogerou A, Panagiotakos D, Zampeli E, Argyris A, Arida K, Konstantonis G
Arthritis Res Ther. 2013; 15(5):R142.
PMID: 24286134
PMC: 3978881.
DOI: 10.1186/ar4324.
